Drug Controller raid uncovers counterfeit version of Sun Pharma's Montek-LC being sold in Telangana
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2025-01-02 09:33 GMT | Update On 2025-01-02 09:33 GMT
Telangana: Drugs Control Administration (DCA), Telangana, seized Spurious Drugs (Counterfeit Versions) 'Montek-LC' Tablets (Montelukast Sodium and Levocetirizine Hydrochloride Tablets), falsely claimed to be manufactured by Sun PharmaLaboratories Ltd.
Based on intelligence gathered by Drugs Control Administration officials, raids were conducted at several dealers in Hyderabad, leading to the detection of Spurious Drugs (Counterfeit Versions) ‘Montek-LC’ Tablets (Montelukast Sodium and Levocetirizine Hydrochloride Tablets) circulating in the market.
‘Montek-LC’ Tablets are used in the management of signs and symptoms of allergic rhinitis, chronic idiopathic urticaria and bronchial asthma.
During the raids, Drugs Inspectors detained the stocks and obtained a comparison statement for the suspected batches from the original manufacturer, Sun Pharma Laboratories Ltd., with the original batches. The manufacturer also concluded that the batch of ‘Montek-LC’ Tablets (Montelukast Sodium and Levocetirizine Hydrochloride Tablets) detained by the Drugs Control Administration were “Spurious Drugs/Counterfeit Drugs”.
During the raid conducted on 31st December, 2024 at Hyper Pharma, Door No.: 17-1-375/1/1/3, Shop No 34, Santosh Nagar, Malakpet, Hyderabad, seized a counterfeit version of ‘Montek-LC’ Tablets (Montelukast Sodium and Levocetirizine Hydrochloride Tablets), Batch No.: SIE1911A, Mfg. Date: 07/2023, Exp. Date: 12/2025, falsely claimed to be manufactured by Sun Pharma Laboratories Ltd., Plot No.107-108, Namli Block, P.O Ranipool, East-Sikkim.
Sri. G. Anil, Drugs Inspector, Malakpet and Sri. B. Govind Singh, Drugs Inspector, Secunderabad carried out the raids. Further investigation will be conducted, and appropriate action will be taken against all offenders. Spurious drugs pose a significant threat to public health, endangering patients' well-being. These drugs not only fail to treat the intended disease but also can lead to severe health complications over time.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.